Legal issues concerning electronic health information - Privacy, quality, and liability

被引:115
作者
Hodge, JG
Gostin, LO
Jacobson, PD
机构
[1] Georgetown Univ, Ctr Law, Washington, DC 20013 USA
[2] Univ Michigan, Sch Publ Hlth, Ann Arbor, MI 48109 USA
来源
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 1999年 / 282卷 / 15期
关键词
D O I
10.1001/jama.282.15.1466
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Personally identifiable health information about individuals and general medical information is increasingly available in electronic form in health databases and through online networks. The proliferation of electronic data within the modern health information infrastructure presents significant benefits for medical providers and patients, including enhanced patient autonomy, improved clinical treatment, advances in health research and public health surveillance, and modern security techniques. However, it also presents new legal challenges in 3 interconnected areas: privacy of identifiable health information, reliability and quality of health data, and tort-based liability. Protecting health information privacy (by giving individuals control over health data without severely restricting warranted communal uses) directly improves the quality and reliability of health data (by encouraging individual uses of health services and communal uses of data), which diminishes tort-based liabilities (by reducing instances of medical malpractice or privacy invasions through improvements in the delivery of health care services resulting in part from better quality and reliability of clinical and research data). Following an analysis of the interconnectivity of these 3 areas and discussing existing and proposed health information privacy laws, recommendations for legal reform concerning health information privacy are presented. These include (1) recognizing identifiable health information as highly sensitive, (2) providing privacy safeguards based on fair information practices, (3) empowering patients with information and rights to consent to disclosure (4) limiting disclosures of health data absent consent, (5) incorporating industry-wide security protections, (6) establishing a national data protection authority, and (7) providing a national minimal level of privacy protections.
引用
收藏
页码:1466 / 1471
页数:6
相关论文
共 59 条
  • [1] [Anonymous], 1991, FED REGISTER
  • [2] [Anonymous], ALBANY LAW REV
  • [3] [Anonymous], 1996, DATA PRIVACY LAW STU
  • [4] ASHTON G, 1998, AM MED NEWS, V41, P26
  • [5] Bashshur R L, 1995, Telemed J, V1, P19, DOI 10.1089/tmj.1.1995.1.19
  • [6] Effect of computerized physician order entry and a team intervention on prevention of serious medication errors
    Bates, DW
    Leape, LL
    Cullen, DJ
    Laird, N
    Petersen, LA
    Teich, JM
    Burdick, E
    Hickey, M
    Kleefield, S
    Shea, B
    Vander Vliet, M
    Seger, DL
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (15): : 1311 - 1316
  • [7] Beauchamp T., 2009, Principles of biomedical ethics, V6
  • [8] BOODMAN SG, 1999, WASHINGTON POST 0608, pH12
  • [9] The origin, content, and workload of e-mail consultations
    Borowitz, SM
    Wyatt, JC
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (15): : 1321 - 1324
  • [10] CHANDRASEKARAN R, 1998, WASH POST 0308, pA1